Clinical Values of Mature Fistulas in Hemodialysis

Last updated: August 16, 2020
Sponsor: Shanghai Zhongshan Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04416971
Mature Fistulas
  • Ages 18-80
  • All Genders

Study Summary

The arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis(HD), and fistula-first is the general recommendation for all HD patients. But in clinical practice in China, quite a few patients start HD before AVF maturation due to various situations. Whether HD initiation with mature AVF will influence the patency and complications is controversial. This study is aim to compare the AVF patency in incident HD patients with mature or immature AVF on HD initiation, and to compare other clinical outcomes, including abandonment without use, infection, and other AVF complications occurrence.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • underwent initial upper-extremity AVF creation for incident HD at Zhongshan Hospital,Fudan University

Exclusion

Exclusion Criteria:

  • with malignancies

  • not followed-up at Zhongshan Hospital, Fudan University

Study Design

Total Participants: 100
Study Start date:
August 20, 2020
Estimated Completion Date:
November 20, 2021

Connect with a study center

  • No.180, Fenglin Road, Xuhui District

    Shanghai, Shanghai 200032
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.